KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $46.4 million.

  • West Pharmaceutical Services' Depreciation & Amortization (CF) rose 1658.29% to $46.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $168.6 million, marking a year-over-year increase of 1106.72%. This contributed to the annual value of $168.6 million for FY2025, which is 1106.72% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Depreciation & Amortization (CF) of $46.4 million as of Q4 2025, which was up 1658.29% from $42.3 million recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Depreciation & Amortization (CF) high stood at $46.4 million for Q4 2025, and its period low was $27.7 million during Q2 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $34.1 million (2023), whereas its average is $34.4 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Depreciation & Amortization (CF) tumbled by 681.11% in 2022, and later surged by 2041.52% in 2023.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Depreciation & Amortization (CF) stood at $32.3 million in 2021, then dropped by 6.81% to $30.1 million in 2022, then rose by 14.95% to $34.6 million in 2023, then rose by 15.03% to $39.8 million in 2024, then grew by 16.58% to $46.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $46.4 million in Q4 2025, compared to $42.3 million in Q3 2025 and $40.8 million in Q2 2025.